Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin for treatment of autosomal dominant polycystic kidney disease
2007-006557-25Phase 2Completed
- Sponsor
- Policlinico di Bari
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sirolimus in autosomal dominant polycystic kidney disease (ADPKD) (2 arms), sponsored by Policlinico di Bari. Primary endpoint: Composite renal progression endpoint. Started Dec 2007; status: completed.
02
Drugs
sirolimus
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on 2007-006557-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006557-25.